Evidence map›Paper›PMID 37248980›Full record

ArticleZhonghua gan zang bing za zhi = Zhonghua ganzangbing zazhi = Chinese journal of hepatology2023

[The regulation of APGAT4 on the growth and lenvatinib resistance of hepatocellular carcinoma].

Z Li, N H Yang, B Li, C Y Sun

Open access · greenAbstract readEnglish Abstract
In one paragraph

Article in Zhonghua gan zang bing za zhi = Zhonghua ganzangbing zazhi = Chinese journal of hepatology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 2 citations in OpenAlex.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Z LiThe Second Affiliated Hospital of Soochow University, Suzhou 215004, China Department of Hepatobiliary Surgery, the Affiliated Hospital of Guizhou Medical University, Guiyang 550004, China.
N H YangDepartment of Hepatobiliary Surgery, the Affiliated Hospital of Guizhou Medical University, Guiyang 550004, China.
B LiDepartment of Hepatobiliary Surgery, the Affiliated Hospital of Guizhou Medical University, Guiyang 550004, China.
C Y SunThe Second Affiliated Hospital of Soochow University, Suzhou 215004, China Guizhou Medical University, Guiyang 550004, China.
Guiyang Medical University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Carcinoma, HepatocellularLiver NeoplasmsAnimalsCell Line, TumorCell ProliferationGene Expression Regulation, NeoplasticMiceMice, NudePhenylurea CompoundsQuinolinesRNA, MessengerlenvatinibPhenylurea CompoundsQuinolinesRNA, Messenger1-acyl-sn-glycerol-3-phosphate acyltransferaseδHepatocellular carcinomaLenvatinib resistanceTumor growth

Identifiers

PMID37248980
PMCPMC12813904
OpenAlexW4378745268

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.